Home | Products | News | Contact Us
   

Nutraceutical News

Australia rethinks nutrient labelling and health claims standards
EFSA approves new vitamins and minerals for foods and supplements
Children positive on organic, free-range and hormone-free
Calcium sales growth suffering from lack of novelty
West follow East's functional lead?
Women Looking For An Alternative To Black Cohosh






 

Saccharomyces Boulardii Clinical Study


Effects of Saccharomyces boulardii on intestinal mucosa.

Buts JP, De Keyser N.

Laboratory of Pediatric Gastroenterology and Nutrition, Unit of Pediatric Research, Universite Catholique de Louvain, Louvain, Belgium. buts@gype.ucl.ac.be

Saccharomyces boulardii (S. boulardii) is a non-pathogenic biotherapeutic agent, widely prescribed in a lyophilized form in many countries over the world. S. boulardii acts as a shuttle liberating effective enzymes, proteins and trophic factors during its intestinal transit that improve host immune defenses, digestion, and absorption of nutrients. In addition, S. boulardii secretes during its intestinal transit polyamines, mainly spermine and spermidine that regulate gene expression and protein synthesis. In this review, we will focus on the interactions of the yeast with the host intestinal mucosa.

PMID: 16838119 [PubMed - indexed for MEDLINE]


<< Back to All Natural Products List

© Copyright 2007 - Nutraceutical Ingredients - All Rights Reservec